Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles

Seaport Therapeutics CEO Daphne Zohar discusses the company's successful IPO, while notable news includes an obesity pill battle between Eli Lilly and Novo Nordisk, and FDA Commissioner Marty Makary faces White House troubles. This is the 400th episode of a biotech podcast. The episode covers various biotech news including a Phase 3 study win for Cytokinetics.